Dublin, Sept. 19, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Antithrombotic/Anticoagulant Drugs - Technologies and Global Markets" report to their offering.
This report is a comprehensive business tool designed to provide an in-depth look at antithrombotic/anticoagulant drugs for various cardiovascular applications. The geographic scope of the report is global, with a special emphasis on individual regions such as the United States, Europe, Asia-Pacific and the rest of world. The report describes the industry, its relationship to the healthcare industry and its participants and future trends.
This report provides:
- An overview of the global market for antithrombotic/anticoagulant drugs, which is changing due to factors such as an aging population, an increase in thrombotic events, and recent advances in pharmaceuticals
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021
- Breakdowns of the market size of anticoagulants by revenue at manufacturers' sales levels, including low molecular weight heparins and oral anticoagulants, as well as breakdowns of antiplatelets and thrombin inhibitors
- Discussion of research and development of antithrombotic/anticoagulant treatments
- Profiles of top leaders in each of the market segments along with companies that are novel or have specific interest to the field
Categories discussed in the report include:
- Anticoagulants.
- Antiplatelets.
- Thrombin inhibitors.
All categories are discussed in detail, describing each segment, identifying current products on the market, measuring market size, identifying market drivers, forecasting for 2016 to 2021 and assessing the competitors their market shares. Key Topics Covered: 1: Introduction Study Goals And Objectives Reasons For Doing This Study Scope Of The Study Methodology And Information Sources 2: Executive Summary Executive Summary 3: Industry Overview Major Developments Sales Performance Of Major Drugs Projected Through 2020 Patent Analysis Epidemic Of Cardiovascular Disease Classification Of Cardiovascular Diseases The Circulatory System Conditions Hemostasis (The Clotting Process) Diseases Associated With Thromboembolism Demographics 4: Anticoagulants Overview Products Oral Anticoagulants (Vitamin K Antagonists) Global Market Forecast Competitive Analysis 5: Antiplatelets Overview Products Global Market Forecast Competitive Analysis 6: Thrombin Inhibitors Overview Products Global Thrombin Inhibitor Market Forecast Research And Development Global Anticoagulant/Antithrombotic Market Forecast Competitive Analysis 7: Company Profiles Abbott Laboratories Armetheon Inc. Astrazeneca Baxter International Bayer AG Biovascular Inc. Boehringer Ingelheim Gmbh Bristol-Myers Squibb Co. CSL Behring Daiichi Sankyo Co. Ltd. Eli Lilly Emisphere Technologies F. Hoffmann-La Roche AG Genentech Glaxosmithkline Johnson & Johnson Ligand Pharmaceuticals Inc. The Medicines Co. Merck Merrion Pharmaceuticals Ltd. Microbix Biosystems Inc. Novartis ONO Pharmaceutical Co. Ltd. Otsuka Pharmaceutical Co. Ltd. Pfizer Inc. Portola Pharmaceuticals Revo Biologics Inc. Sanofi Santa Cruz Biotechnology Inc. Servier Laboratories Shire Pharmaceuticals Sun Pharmaceuticals TEVA Pharmaceuticals Ltd. 8: Appendix A: List Of Patents Table 57 : List Of Patents On Antithrombotics And Anticoagulants, 2011-April 2016 9: Appendix B: Directory Of Companies Covered In This Report For more information about this report visit http://www.researchandmarkets.com/research/cz...omboticant Related Topics: Hematological Drugs
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
